Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ola Landgren

Showing results (81-90 of 519) with videos related to

Pageof 52
Sort By:
Journal of the American Geriatrics Society|January 28, 2005
Familial longevity: the older you are, the older your father may have beenOla Landgren, Magnus Björkholm, Fredrik Granath, et al.
Blood|July 25, 2006
Immune thrombocytopenic purpura does not exhibit a disparity in prevalence between African American and White veteransOla Landgren, Gloria Gridley, Thomas R Fears, et al.
Expert Review of Molecular Diagnostics|May 15, 2010
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosisArun Balakumaran, Pamela Gehron Robey, Neal Fedarko, et al.
Mayo Clinic Proceedings|March 3, 2010
Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinicIngemar Turesson, Ramon Velez, Sigurdur Y Kristinsson, et al.
Blood|June 21, 2013
Pursuing the curative blueprint for early myelomaMark Roschewski, Neha Korde, S Peter Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based studyIngemar Turesson, Ramon Velez, Sigurdur Y Kristinsson, et al.
Archives of Internal Medicine|June 15, 2007
Risk of malignant disease among 1525 adult male US Veterans with Gaucher diseaseOla Landgren, Ingemar Turesson, Gloria Gridley, et al.
American Journal of Hematology|August 25, 2016
Myeloma minimal residual disease testing in the United States: Evidence of improved standardizationDalia Salem, Maryalice Stetler-Stevenson, Constance Yuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
Dilemmas in treating smoldering multiple myelomaInhye E Ahn, Sham Mailankody, Neha Korde, et al.
Blood|February 2, 2008
Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disordersLinda Morris Brown, Gloria Gridley, David Check, et al.
Pageof 52

Showing results (81-90 of 519) with videos related to

Sort By:
Pageof 52
Journal of the American Geriatrics Society|January 28, 2005
Familial longevity: the older you are, the older your father may have beenOla Landgren, Magnus Björkholm, Fredrik Granath, et al.
Blood|July 25, 2006
Immune thrombocytopenic purpura does not exhibit a disparity in prevalence between African American and White veteransOla Landgren, Gloria Gridley, Thomas R Fears, et al.
Expert Review of Molecular Diagnostics|May 15, 2010
Bone marrow microenvironment in myelomagenesis: its potential role in early diagnosisArun Balakumaran, Pamela Gehron Robey, Neal Fedarko, et al.
Mayo Clinic Proceedings|March 3, 2010
Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinicIngemar Turesson, Ramon Velez, Sigurdur Y Kristinsson, et al.
Blood|June 21, 2013
Pursuing the curative blueprint for early myelomaMark Roschewski, Neha Korde, S Peter Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based studyIngemar Turesson, Ramon Velez, Sigurdur Y Kristinsson, et al.
Archives of Internal Medicine|June 15, 2007
Risk of malignant disease among 1525 adult male US Veterans with Gaucher diseaseOla Landgren, Ingemar Turesson, Gloria Gridley, et al.
American Journal of Hematology|August 25, 2016
Myeloma minimal residual disease testing in the United States: Evidence of improved standardizationDalia Salem, Maryalice Stetler-Stevenson, Constance Yuan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2014
Dilemmas in treating smoldering multiple myelomaInhye E Ahn, Sham Mailankody, Neha Korde, et al.
Blood|February 2, 2008
Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disordersLinda Morris Brown, Gloria Gridley, David Check, et al.
Pageof 52